A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/03/2011	WO2011104723A3 Acid addition salts of ivabradine and preparation method thereof
11/03/2011	WO2011104414A3 Compounds for treating alzheimer's disease
11/03/2011	WO2011104411A3 Compounds for treating alzheimer's disease
11/03/2011	WO2011098839A3 Di -aspirin derivatives for use in the treatment of colorectal cancer
11/03/2011	WO2011098408A3 Hydrazine-substituted anthranilic acid derivatives
11/03/2011	WO2011089576A3 Novel compositions for reducing abeta 42 production and their use in treating alzheimer's disease (ad)
11/03/2011	WO2011088055A3 Methionine aminopeptidase 2 (metap2) inhibitors for treating cardiovascular or cerebrovascular disorders
11/03/2011	WO2011085256A3 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
11/03/2011	WO2011083401A3 A composition and dispenser for personal hygiene
11/03/2011	WO2011082400A3 Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
11/03/2011	WO2011082290A3 Formulations from natural products, turmeric, and aspirin
11/03/2011	WO2011082175A3 Glycosaminoglycan inhibitors
11/03/2011	WO2011080570A3 Extended release pharmaceutical composition comprising linezolid and process for preparing the same
11/03/2011	WO2011075699A3 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/03/2011	WO2011074791A3 Pharmaceutical composition containing telmisartan and hydrochlorothiazide
11/03/2011	WO2011068934A3 Vaccine against neoplastic or cancerous lesions caused by human papillomavirus (hpv), procedures, uses and methods
11/03/2011	WO2011065677A3 Pharmaceutical composition for treating cancer
11/03/2011	WO2011063415A9 Methods for treating mild cognitive impairment
11/03/2011	WO2011062458A3 Composition containing homoisoflavanone as active ingredient for preventing and treating obesity or metabolic syndrome
11/03/2011	WO2011062437A3 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/03/2011	WO2011062372A3 2, 4, 7 -substituted thieno [3, 2 -d] pyrimidine compounds as protein kinase inhibitors
11/03/2011	WO2011061516A3 Topical foam composition
11/03/2011	WO2011060440A3 Kinase inhibitors
11/03/2011	WO2011060354A3 Coloring composition containing an aromatic compound and an initiator
11/03/2011	WO2011059294A3 Anticancer and immunity-enhancing composition containing morphinan alkaloids as active ingredients
11/03/2011	WO2011056021A3 Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis
11/03/2011	WO2011055944A3 Methods for treating fibromyalgia syndrome
11/03/2011	WO2011055917A3 Arginine derivatives or salts thereof exhibiting the effects of improving sexual function, composition for improving sexual function comprising same, and method for preparing same
11/03/2011	WO2011053090A3 Novel 2, 4-pyrimidine derivatives and use thereof
11/03/2011	WO2011053048A3 Novel vascular leak inhibitor
11/03/2011	WO2011052968A3 Composition for preventing or treating degenerative neurological disorder, containing oleanonic acid
11/03/2011	WO2011052919A3 Novel alpha-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition for an immune adjuvant, containing the derivatives as active ingredients
11/03/2011	WO2011049540A3 The pharmaceutical composition in dry powder form for inhalation
11/03/2011	WO2011049538A3 Pharmaceutical composition in dry powder form
11/03/2011	WO2011049400A3 Pharmaceutical composition containing acid addition salt of n,n-dimethyl imidocarbonimidic diamide for anti-cancer
11/03/2011	WO2011043631A3 Pharmaceutical composition for preventing and treating cold, containing reynoutria elliptica extract, fraction thereof or stilbene-based compound
11/03/2011	WO2010143970A3 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
11/03/2011	WO2010132760A9 Antibacterial derivatives of tobramycin
11/03/2011	WO2010120414A3 Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
11/03/2011	WO2010116282A8 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
11/03/2011	WO2009085310A8 Extended-release pharmaceutical compositions containing zolpidem
11/03/2011	US20110271356 Hcv entry factor, occludin
11/03/2011	US20110270259 Paste-powder dual polymer-based bone cement and injection apparatus for same
11/03/2011	US20110270215 composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor
11/03/2011	US20110270156 High shear application in medical therapy
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110270011 Use of opioids or opioid mimetics for the treatment of resistant cancer patients
11/03/2011	US20110269970 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
11/03/2011	US20110269947 Apo-2 ligand/trail formulations
11/03/2011	US20110269847 Storage-stable compositions of glycerol monoalkyl ethers
11/03/2011	US20110269844 Thin film with propofol active ingredient
11/03/2011	US20110269843 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
11/03/2011	US20110269842 Compositions comprising cb receptor agonists, uses thereof and methods for their preparation
11/03/2011	US20110269841 Thin film with methadone active ingredient
11/03/2011	US20110269840 Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde
11/03/2011	US20110269839 Anti-snoring composition containing a termogelling polymer
11/03/2011	US20110269838 Novel processes and pure polymorphs
11/03/2011	US20110269837 Phosphorus binder composition for treatment of hyperphosphatemia
11/03/2011	US20110269836 Intrathecal baclofen pharmaceutical dosage forms and related delivery system
11/03/2011	US20110269834 Compounds and methods for treating respiratory diseases
11/03/2011	US20110269833 Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
11/03/2011	US20110269831 Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids
11/03/2011	US20110269830 Statin nanoparticles
11/03/2011	US20110269829 Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same
11/03/2011	US20110269828 Compositions and methods for treating and preventing weight-related disorders in companion animals
11/03/2011	US20110269827 Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals
11/03/2011	US20110269825 Modified Thromboxane A2 Receptor Promoter Sequence
11/03/2011	US20110269824 Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer
11/03/2011	US20110269823 Compositions And Methods For Inhibiting Expression Of The HAMP Gene
11/03/2011	US20110269822 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
11/03/2011	US20110269821 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
11/03/2011	US20110269820 Spinal muscular atrophy treatment via targeting smn2 catalytic core
11/03/2011	US20110269819 Methods and compositions for targeting skip
11/03/2011	US20110269818 Modulation of prion expression
11/03/2011	US20110269817 Compositions and methods related to sirt1 function
11/03/2011	US20110269816 Inhibition of Viral Gene Expression Using Small Interfering RNA
11/03/2011	US20110269815 Methods of reducing cellular proliferation by inhibiting acsvl3
11/03/2011	US20110269814 2'-f modified rna interference agents
11/03/2011	US20110269813 Gene Silencing by Single-Stranded Polynucleotides
11/03/2011	US20110269812 Novel benzylidene-indolinone and their medical and diagnostic uses
11/03/2011	US20110269811 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
11/03/2011	US20110269810 Selective inhibitors of c-jun n-terminal kinase
11/03/2011	US20110269809 Spiroindolinone pyrrolidines
11/03/2011	US20110269808 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases
11/03/2011	US20110269807 Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
11/03/2011	US20110269806 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
11/03/2011	US20110269805 Method of treating sensorimotor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
11/03/2011	US20110269803 Azole compounds used as tuberculostatic and leishmanicide agents
11/03/2011	US20110269802 Method of delivery of perishable liquid mixtures using mixing cap and container system
11/03/2011	US20110269801 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
11/03/2011	US20110269800 P38 map kinase inhibitors
11/03/2011	US20110269799 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
11/03/2011	US20110269798 Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer
11/03/2011	US20110269797 Anln protein as an endocrine treatment predictive factor
11/03/2011	US20110269796 Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines
11/03/2011	US20110269795 Use of glucosidase inhibitors for therapy of mucovisidosis
11/03/2011	US20110269794 External Preparation for Athlete's Foot Treatment
11/03/2011	US20110269793 Method for preventing tau protein aggregation and treating alzheimer's disease with a quinoline derivative compound
11/03/2011	US20110269792 Compositions useful for treating irritable bowel syndrome
11/03/2011	US20110269791 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use

1 ... 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 ... 7860